Biologics, Wound Care, Infection Prevention
Avista to acquire Organogenesis
Avista Healthcare Public Acquisition Corp., a publicly traded special purpose acquisition company, and Organogenesis Inc., a leading regenerative medicine company focused on the development, manufacture and commercialization of product solutions for the Advanced Wound Care, Surgical and Sports Medicine markets, today announced that they have entered into a definitive merger agreement, under which Organogenesis will…
Read MoreMolecuLight’s First-of-its-kind Handheld Wound Imaging Device Receives FDA De Novo Clearance
MolecuLight Inc. achieved a major regulatory milestone permitting expansion into the United States market. FDA has granted De Novo clearance for the ground-breaking wound fluorescence imaging device, the MolecuLight i:X. The device digitally captures and documents fluorescence information from wounds and surrounding tissue using still images and videos in real-time. This product is optimized for use at the point-of-care. It…
Read MoreInnovative Bedside Biologic Maker RedDress Receives 510(k) for RD1 System
RedDress Ltd announced today that it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its RD1 system. RD1 is an innovative wound care product which enables health care providers to produce in real time, in vitro whole blood clots, for use as a chronic wound care product. It has been developed to…
Read MoreImplantable Organ Developer Miromatrix Raises Additional $15.7M in Series B Funding
July 12, 2018 – Press Release by Miromatrix Medical Miromatrix Medical Inc. is excited to announce it recently raised $15.7 million in Series B-2 funding, surpassing its goal of $10 million. As part of the round, Miromatrix also welcomed its first large strategic investor, a multibillion-dollar health care company. The additional funding supports the company’s…
Read MoreMiMedx CEO and President Out Amid Corporate Turmoil
MiMedx, the Marietta biopharma company rocked by allegations of inflated earnings and improper sales practices, said Monday the company’s longtime chairman and CEO has resigned. Parker H. “Pete” Petit, a fixture in metro Atlanta’s business community, resigned both as CEO and chairman, though he will remain a member of the MiMedx board, the company said in…
Read MoreFirst Jellyfish-based biologics manufacturer receives funding
Jellagen, a pioneer in marine biotechnologies based in Wales, has closed a £3.8m funding round led by Newable Private Investing, the Development Bank of Wales, and Angel Investors. Newable Private Investing is one of the UK’s leading private investment groups, providing support to cutting-edge start-ups. As the first commercial manufacturer of next-generation jellyfish collagen for…
Read MoreGraphene spikes on implants can kill harmful bacteria
A tiny layer of graphene flakes becomes a deadly weapon and kills bacteria, stopping infections during procedures such as implant surgery. This is the findings of new research from Chalmers University of Technology, Sweden, recently published in the scientific journal Advanced Materials Interfaces. Operations for surgical implants, such as hip and knee replacements or dental…
Read MoreAirAlle Medical Device for Head Lice
Chelmsford, Massachusetts, April 03, 2018 (GLOBE NEWSWIRE) — Lynn Smith spent most of her career marketing advances in medical technology as a sales and business development executive for biotech companies. When the Smith family was confronted with head lice for the first time, and traditional solutions failed, she turned to a proven medical device solution…
Read MoreFDA Keeps Contraceptive on Market After it Makes Women Sick
Last month, Food and Drug Administration Commissioner Scott Gottlieb met with a group of women who’ve been knocking on the agency’s door for years. Online, they’re known as E-sisters: women who were implanted with the permanent “non-incisional” contraceptive called Essure, which consists of metal coils that are implanted into the fallopian tubes and contain nickel. The E-sisters…
Read MoreWorm’s Living in Woman’s Eye Lead to Interesting Discovery
(CNN) Imagine looking into your irritated eye for a pesky eyelash, only to pull out a translucent, wiggling worm nearly a half inch long. “I looked at it, and it was moving,” recalled 28-year-old Abby Beckley of Grants Pass, Oregon. “And then it died within about five seconds.” Now, imagine doing that not once but 14…
Read More